Zydus Cadila receives US FDA nod for antifungal drug nystatin

Nesher Pharmaceuticals, a subsidiary of Zydus Pharmaceuticals USA, has recevied final approval from the US Food & Drug Administration (FDA) to market nystatin topical powder (100,000 units per gram). The drug will be produced at the Nesher Pharmaceuticals' manufacturing facility located at St. Louis, Missouri (USA). Nystatin topical powder is an antifungal antibiotic used to treat skin infections caused by yeast.